Mammary analogue secretory carcinoma of the salivary glands.

ETV6-NTRK3 translocation mammary secretory carcinoma molecular pathology salivary glands

Journal

Ecancermedicalscience
ISSN: 1754-6605
Titre abrégé: Ecancermedicalscience
Pays: England
ID NLM: 101392236

Informations de publication

Date de publication:
2023
Historique:
received: 22 04 2022
medline: 28 4 2023
pubmed: 28 4 2023
entrez: 28 4 2023
Statut: epublish

Résumé

Mammary analogue secretory carcinoma (MASC) is a new disease among tumours affecting the salivary glands. It was first reported in 2010, and few cases have been reported worldwide. MASC is often incorrectly diagnosed as salivary gland acinic cell carcinoma. We present here the case of a patient with an asymptomatic parotid tumour who underwent a parotidectomy of the superficial lobe. A 78-year-old female patient came to the clinic for a tumour of approximately 2.5 × 2.5 cm and a hard, elastic consistency that had grown insidiously in the right preauricular region. Magnetic resonance imaging of the head and neck showed a heterogeneous ovoid lesion located in the lower part of the superficial lobe of the right parotid gland, measuring 29 × 27 × 27 mm. A superficial parotidectomy was performed with the facial nerve identified and preserved. Immunohistochemistry was positive for S100, mammaglobin, periodic acid Schiff (PAS) and GATA-3. Fluorescence in situ hybridisation analysis was subsequently performed and Translocation-ETS-Leukemia Virus (ETV6) gene rearrangement observed. These findings were consistent with diagnosis of a MASC. The patient then required no new interventions or adjuvant therapy. At publication, she was free of disease and continues in clinical follow-up. MASC is a tumour of the saliva glands that is recently described and rare. There are no studies that describe its biological behaviour or prognosis precisely.

Sections du résumé

Background UNASSIGNED
Mammary analogue secretory carcinoma (MASC) is a new disease among tumours affecting the salivary glands. It was first reported in 2010, and few cases have been reported worldwide. MASC is often incorrectly diagnosed as salivary gland acinic cell carcinoma. We present here the case of a patient with an asymptomatic parotid tumour who underwent a parotidectomy of the superficial lobe.
Case report UNASSIGNED
A 78-year-old female patient came to the clinic for a tumour of approximately 2.5 × 2.5 cm and a hard, elastic consistency that had grown insidiously in the right preauricular region. Magnetic resonance imaging of the head and neck showed a heterogeneous ovoid lesion located in the lower part of the superficial lobe of the right parotid gland, measuring 29 × 27 × 27 mm. A superficial parotidectomy was performed with the facial nerve identified and preserved. Immunohistochemistry was positive for S100, mammaglobin, periodic acid Schiff (PAS) and GATA-3. Fluorescence in situ hybridisation analysis was subsequently performed and Translocation-ETS-Leukemia Virus (ETV6) gene rearrangement observed. These findings were consistent with diagnosis of a MASC. The patient then required no new interventions or adjuvant therapy. At publication, she was free of disease and continues in clinical follow-up.
Conclusion UNASSIGNED
MASC is a tumour of the saliva glands that is recently described and rare. There are no studies that describe its biological behaviour or prognosis precisely.

Identifiants

pubmed: 37113723
doi: 10.3332/ecancer.2023.1511
pii: can-17-1511
pmc: PMC10129378
doi:

Types de publication

Case Reports

Langues

eng

Pagination

1511

Informations de copyright

© the authors; licensee ecancermedicalscience.

Déclaration de conflit d'intérêts

There are no conflicts of interest to declare in this publication.

Références

Am J Surg Pathol. 2020 Oct;44(10):1295-1307
pubmed: 32675658
Int J Clin Exp Pathol. 2019 Dec 01;12(12):4338-4343
pubmed: 31933835
Cancer Cell. 2002 Nov;2(5):367-76
pubmed: 12450792
Am J Surg Pathol. 2010 May;34(5):599-608
pubmed: 20410810
Oral Oncol. 2018 Jul;82:29-33
pubmed: 29909898
Med Oral Patol Oral Cir Bucal. 2015 Jan 01;20(1):e23-9
pubmed: 25481229
Hum Pathol. 2017 Aug;66:10-12
pubmed: 28583885
Am J Surg Pathol. 2018 Feb;42(2):234-246
pubmed: 29076873
Am J Surg Pathol. 2014 Jan;38(1):23-33
pubmed: 24145651
Head Neck Pathol. 2013 Jul;7 Suppl 1:S30-6
pubmed: 23821207
Histopathology. 2012 Sep;61(3):387-94
pubmed: 22372712
Int J Surg Case Rep. 2019;55:88-91
pubmed: 30716709
J Oral Maxillofac Surg. 2022 Jan;80(1):101-112
pubmed: 34653372

Auteurs

Lucas Avondet (L)

Department of Surgery, Head and Neck Unit, Angel H Roffo Oncology Institute (IOAHR), C1417 CABA, Buenos Aires, Argentina.

Roque Adan (R)

Department of Surgery, Head and Neck Unit, Angel H Roffo Oncology Institute (IOAHR), C1417 CABA, Buenos Aires, Argentina.

Barbara M Berenstein (BM)

Department of Surgery, Head and Neck Unit, Angel H Roffo Oncology Institute (IOAHR), C1417 CABA, Buenos Aires, Argentina.

Ismael Tayagui (I)

Department of Surgery, Head and Neck Unit, Angel H Roffo Oncology Institute (IOAHR), C1417 CABA, Buenos Aires, Argentina.

Gonzalo Zeballos (G)

Department of Surgery, Head and Neck Unit, Angel H Roffo Oncology Institute (IOAHR), C1417 CABA, Buenos Aires, Argentina.

Erica Rojas Bilbao (ER)

Department of Anatomical Pathology, Angel H Roffo Oncology Institute (IOAHR), C1417 CABA, Buenos Aires, Argentina.

Fernanda Alsina (F)

Department of Anatomical Pathology, Angel H Roffo Oncology Institute (IOAHR), C1417 CABA, Buenos Aires, Argentina.

Nicolas Bustos (N)

Department of Diagnostic Imaging, Angel H Roffo Oncology Institute (IOAHR), C1417 CABA, Buenos Aires, Argentina.

Classifications MeSH